Nanoparticle-Mediated Therapeutic Approach for Ulcerative Colitis Treatment

Author:

Banerjee Subhamoy1

Affiliation:

1. B. S. Abdur Rahman Crescent Institute of Science and Technology, India

Abstract

Ulcerative colitis is a chronic inflammation of the inner part of the colonic mucosa. It is a type of inflammatory bowel disease which is idiopathic in nature. It is multifactorial, debilitating disorder which may cause life threatening complications. Given to the architecture of colon, conventional medicines have limitation in treating the disease. Thus, the need for alternative methods of drug delivery is important. Nanoparticle is one of the preferred drug delivery system owing to its unique properties. Nanoparticles resist undesired and premature degradation of the drugs, increases bioavailability, and target specificity. Different nanoparticle-based drug delivery systems like metallic, liposome, silica, or polymeric nanoparticles have been designed to administer therapeutic agents through oral route to treat ulcerative colitis. Natural compounds and active components isolated from the plant extracts and other bioactive agents are also delivered by nanoparticle. In the current chapter, nanoparticle-mediated drug and phytochemicals delivery to treat ulcerative colitis are discussed.

Publisher

IGI Global

Reference58 articles.

1. Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression

2. Afzali, A. (2019). The Impact of Racial and Ethnic Differences in Inflammatory Bowel Disease Phenotype in the United States. e-WGN Expert Point of View Articles Collection.https://www.worldgastroenterology.org/publications/e-wgn/e-wgn-expert-point-of-view-articles-collection/the-impact-of-racial-and-ethnic-differences-in-ibd-phenotype-in-the-us

3. Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC

4. Biological therapy for ulcerative colitis

5. Embelin lipid nanospheres for enhanced treatment of ulcerative colitis – Preparation, characterization and in vivo evaluation

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. A REVIEW ON PHARMACOLOGICAL AND THERAPEUTIC INSIGHT OF OZANIMOD FOR COLON DISEASE IN NANO-STRUCTURE;International Journal of Pharmacy and Pharmaceutical Sciences;2022-04-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3